BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 23352435)

  • 21. A three-decade analysis of 3,911 small intestinal neuroendocrine tumors: the rapid pace of no progress.
    Modlin IM; Champaneria MC; Chan AK; Kidd M
    Am J Gastroenterol; 2007 Jul; 102(7):1464-73. PubMed ID: 17391319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histologic characterization and improved prognostic evaluation of 209 gastric neuroendocrine neoplasms.
    La Rosa S; Inzani F; Vanoli A; Klersy C; Dainese L; Rindi G; Capella C; Bordi C; Solcia E
    Hum Pathol; 2011 Oct; 42(10):1373-84. PubMed ID: 21531442
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic factors of long-term outcome in gastroenteropancreatic neuroendocrine tumours.
    Pape UF; Berndt U; Müller-Nordhorn J; Böhmig M; Roll S; Koch M; Willich SN; Wiedenmann B
    Endocr Relat Cancer; 2008 Dec; 15(4):1083-97. PubMed ID: 18603570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiology of neuroendocrine tumours.
    Taal BG; Visser O
    Neuroendocrinology; 2004; 80 Suppl 1():3-7. PubMed ID: 15477707
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A retrospective review of diagnosis and treatment modalities of neuroendocrine tumors (excluding primary lung cancer) in 10 oncological institutions of the East German Study Group of Hematology and Oncology (OSHO), 2010-2012.
    Maschmeyer G; Mügge LO; Kämpfe D; Kreibich U; Wilhelm S; Aßmann M; Schwarz M; Kahl C; Köhler S; Grobe N; Niederwieser D
    J Cancer Res Clin Oncol; 2015 Sep; 141(9):1639-44. PubMed ID: 25773126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The incidence, treatment and survival of patients with rare types of rectal malignancies in the Netherlands: A population-based study between 1989 and 2018.
    van Rees JM; Elferink MAG; Tanis PJ; de Wilt JHW; Burger JWA; Verhoef C
    Eur J Cancer; 2021 Jul; 152():183-192. PubMed ID: 34118528
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification.
    Yang Z; Tang LH; Klimstra DS
    Am J Surg Pathol; 2011 Jun; 35(6):853-60. PubMed ID: 21566513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Four Neuroendocrine Tumor Types and Neuroendocrine Carcinoma of the Duodenum: Analysis of 203 Cases.
    Vanoli A; La Rosa S; Klersy C; Grillo F; Albarello L; Inzani F; Maragliano R; Manca R; Luinetti O; Milione M; Doglioni C; Rindi G; Capella C; Solcia E
    Neuroendocrinology; 2017; 104(2):112-125. PubMed ID: 26910321
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Case of Gastric Neuroendocrine Neoplasm with Mixed Grade: a Distinct Type of "High"-grade Well-Differentiated Neuroendocrine Neoplasm.
    Guadagno E; Luglio G; Iacobelli A; Borrelli G; Castaldi A; De Rosa G; Del Basso De Caro M
    Endocr Pathol; 2018 Sep; 29(3):289-293. PubMed ID: 29675587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An overview of the current diagnosis and recent developments in neuroendocrine tumours of the gastroenteropancreatic tract: the diagnostic approach.
    Kuiper P; Verspaget HW; Overbeek LI; Biemond I; Lamers CB
    Neth J Med; 2011 Jan; 69(1):14-20. PubMed ID: 21325696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.
    Raj N; Valentino E; Capanu M; Tang LH; Basturk O; Untch BR; Allen PJ; Klimstra DS; Reidy-Lagunes D
    Pancreas; 2017 Mar; 46(3):296-301. PubMed ID: 27759713
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes.
    Hallet J; Law CH; Cukier M; Saskin R; Liu N; Singh S
    Cancer; 2015 Feb; 121(4):589-97. PubMed ID: 25312765
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence of second primary malignancies in patients with neuroendocrine tumors of the digestive tract and pancreas.
    Kamp K; Damhuis RA; Feelders RA; de Herder WW
    Endocr Relat Cancer; 2012 Feb; 19(1):95-9. PubMed ID: 22194442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognoses of GEP-NETS with undetermined malignant potentials of their primary sites.
    Kudo A; Ban D; Akashi T; Kumagai J; Aihara A; Inokuchi M; Kojima K; Kawano T; Tanaka S; Arii S
    Hepatogastroenterology; 2012 Sep; 59(118):1682-6. PubMed ID: 22584425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.
    Uccella S; La Rosa S; Metovic J; Marchiori D; Scoazec JY; Volante M; Mete O; Papotti M
    Endocr Pathol; 2021 Mar; 32(1):192-210. PubMed ID: 33433884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic and immunohistochemical profiling of small cell and large cell neuroendocrine carcinomas of the breast.
    Bean GR; Najjar S; Shin SJ; Hosfield EM; Caswell-Jin JL; Urisman A; Jones KD; Chen YY; Krings G
    Mod Pathol; 2022 Oct; 35(10):1349-1361. PubMed ID: 35590107
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neuroendocrine tumors of the lung].
    Oliaro A; Donati G; Filosso PL; Ruffini E
    Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours.
    Kim J; Lee WJ; Lee SH; Lee KB; Ryu JK; Kim YT; Kim SW; Yoon YB; Hwang JH; Han HS; Woo SM; Park SJ
    Dig Liver Dis; 2011 Dec; 43(12):965-70. PubMed ID: 21856258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Relapse-free survival in patients with nonmetastatic, surgically resected pancreatic neuroendocrine tumors: an analysis of the AJCC and ENETS staging classifications.
    Strosberg JR; Cheema A; Weber JM; Ghayouri M; Han G; Hodul PJ; Kvols LK
    Ann Surg; 2012 Aug; 256(2):321-5. PubMed ID: 22415420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-grade neuroendocrine carcinoma of the lung: comparative clinicopathological study of large cell neuroendocrine carcinoma and small cell lung carcinoma.
    Sun L; Sakurai S; Sano T; Hironaka M; Kawashima O; Nakajima T
    Pathol Int; 2009 Aug; 59(8):522-9. PubMed ID: 19627535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.